Ben Burnett
Stock Analyst at Stifel
(n/a)
# 4,314
Out of 4,667 analysts
4
Total ratings
n/a
Success rate
-48.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ben Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JSPR Jasper Therapeutics | Initiates: Buy | $86 | $20.98 | +309.91% | 1 | Jun 27, 2024 | |
| CABA Cabaletta Bio | Maintains: Buy | $32 | $2.26 | +1,315.93% | 2 | Jun 17, 2024 | |
| CRSP CRISPR Therapeutics AG | Initiates: Hold | $52 | $47.26 | +10.03% | 1 | Mar 5, 2020 |
Jasper Therapeutics
Jun 27, 2024
Initiates: Buy
Price Target: $86
Current: $20.98
Upside: +309.91%
Cabaletta Bio
Jun 17, 2024
Maintains: Buy
Price Target: $32
Current: $2.26
Upside: +1,315.93%
CRISPR Therapeutics AG
Mar 5, 2020
Initiates: Hold
Price Target: $52
Current: $47.26
Upside: +10.03%